FDA Drug Application (200630) for TADALAFIL by SYNTHON PHARMS

Back to FDA Applications sponsored by SYNTHON PHARMS

Application Number200630
Product Number001
FormTABLET; ORAL
Dosage20MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTADALAFIL
Active IngredientTADALAFIL

Active IngredientCount
List of drugs with Active Ingredient TADALAFIL3


Back to FDA Applications sponsored by SYNTHON PHARMS